Cardio-Oncology is affiliated with the International Cardio-Oncology Society (ICOS).
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
Breast cancer is estimated to comprise about 290,560 new cases in 2022. Aromatase inhibitors (AIs) are recommended as adjuvant treatment for estrogen-receptor positive (ER+) breast carcinoma in postmenopausal ...